The document discusses new methodologies for combining design research and clinical research when developing digital medical products. It introduces two new methods: RCS (Research for Component Selection) which allows for usability testing and engineering experiments under a clinical protocol umbrella; and CLUE (Clinical User Experience) which allows design researchers to work directly with clinical trial participants to test products in real-world use. The document argues that these new methods enable insights to be gained earlier in the product development process by blending design and clinical research approaches in a structured yet nimble way.
Origin and principles of international conference on harmonization- Good clin...AbhishekJoshi312
The ppt gives a basic information about ICH-GCP, how it originated , what led to the formation of ICH-GCP guidelines and what are the principles of the guidelines.
Roles and Responsibilities in Clinical Trials of Investigator, Study Coordinator, Sponsor, Monitor, a Contract research organization.
The clinical trial, definition, description, Different types of clinical trials, phases of clinical trial.
The clinical trial study team.
Requirements of the clinical trial study team.
Clinical research team role.
GCP- Good clinical practices.
Overview of FDA requirements for clinical studies as well as privacy issues, including impact of HIPAA; plus practical considerations in developing clinical studies.
Origin and principles of international conference on harmonization- Good clin...AbhishekJoshi312
The ppt gives a basic information about ICH-GCP, how it originated , what led to the formation of ICH-GCP guidelines and what are the principles of the guidelines.
Roles and Responsibilities in Clinical Trials of Investigator, Study Coordinator, Sponsor, Monitor, a Contract research organization.
The clinical trial, definition, description, Different types of clinical trials, phases of clinical trial.
The clinical trial study team.
Requirements of the clinical trial study team.
Clinical research team role.
GCP- Good clinical practices.
Overview of FDA requirements for clinical studies as well as privacy issues, including impact of HIPAA; plus practical considerations in developing clinical studies.
This presentation is a brief overview of ICH-GCP guidelines. Although ICH-GCP is a very vast topic, still this presentation will cover almost all the points. The reader will be able to discuss about the roles and responsibilities of various personnel in clinical trials.
What is ICH- GCP?
Why is GCP important?
Outline the goals of GCP
Provide a historical perspective on GCP
WHO Principles of GCP
Principles: Defines, Application & Implementation.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
Presentation on Roles and Responsibilities of sponsor in conducting clinical trials as per GCP-ICH for pursuing a subject in the course of PharmD programme under RGUHS
Patient safety has always been the industry’s focus during clinical trials. However, a recent spate of well-publicized patient safety issues have increased public scrutiny and the biotechnology, pharmaceutical and CRO industries' desire to improve study quality, resulting in larger, longer, more expensive trials. In this Q&A, James T. Gourzis, M.D., Ph.D., discusses issues affecting patient safety, including factors that have launched safety to the forefront; what to look for in evaluating CRO excellence; unique oncology considerations and the ramifications of the rare toxicity; optimizing the Data Monitoring Committee; budget decisions that affect patient safety and the evolution/future of FDA requirements.
This presentation is a brief overview of ICH-GCP guidelines. Although ICH-GCP is a very vast topic, still this presentation will cover almost all the points. The reader will be able to discuss about the roles and responsibilities of various personnel in clinical trials.
What is ICH- GCP?
Why is GCP important?
Outline the goals of GCP
Provide a historical perspective on GCP
WHO Principles of GCP
Principles: Defines, Application & Implementation.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
Presentation on Roles and Responsibilities of sponsor in conducting clinical trials as per GCP-ICH for pursuing a subject in the course of PharmD programme under RGUHS
Patient safety has always been the industry’s focus during clinical trials. However, a recent spate of well-publicized patient safety issues have increased public scrutiny and the biotechnology, pharmaceutical and CRO industries' desire to improve study quality, resulting in larger, longer, more expensive trials. In this Q&A, James T. Gourzis, M.D., Ph.D., discusses issues affecting patient safety, including factors that have launched safety to the forefront; what to look for in evaluating CRO excellence; unique oncology considerations and the ramifications of the rare toxicity; optimizing the Data Monitoring Committee; budget decisions that affect patient safety and the evolution/future of FDA requirements.
How medical devices help fill EHRs with clinically useful data for comparative effectiveness research and data interoperability. This talk was given at the IEEE Baltimore Section EMB Society
This whitepaper provides an overview of Chinese Medical Device Regulations. This includes an overview of the Chinese medical device market, medical device regulatory authorities, medical device registration procedure and medical device classification. It also provides information on regulations regarding product standard, type testing, and clinical trials. This paper is meant for anyone within the regulatory affairs industry who is looking to learn more about medical device regulations and product registration in China.
For more information, contact us for a free 15 minute consultation at http://www.pacificbridgemedical.com/contact-us/.
Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies To Ensure...Best Practices
In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities. Emerging markets are also fast-growing regions that present future growth opportunities for organizations that have seen sales growth slow in mature markets. However, there are still questions around the cost, acceptability, quality and pitfalls of conducting clinical trials in emerging regions.
Best Practices®, LLC conducted primary research to inform clinical affairs leaders at medical device companies on emerging approaches to staffing, outsourcing and managing clinical trials outside of the European and U.S. regions.
Critical outsourcing questions addressed in this survey include:
-What are the regions where medical device companies are conducting clinical trials and the percent of patients recruited annually from these regions?
-Which clinical trial activities are best suited for outsourcing?
-What is the appropriate staffing mix (in-house and outsourced) for clinical trials?
-What are the most important competencies for clinical research associates, managers, and directors?
This report will inform Clinical Affairs leaders on these questions and others regarding staffing, outsourcing and managing clinical trials outside of the U.S.
Medical device registration and clinical trial in china (www.cirs md.com)CIRS China
CIRS brochure on medical device registration and clinical trial in China, the more information can be found here: www.cirs-md.com or contact Ms. Lyu via Elaine@cirs-group.com
How to Use Open Source Technologies in Safety-critical Digital Health Applica...Shahid Shah
Presented at 3rd Annual Open Source EHR Summit - Key Takeaways:
* Outcomes driven care (vs. fees for service or volume driven care) is in our future
* Because outcomes now matter more than ever, open source digital health solutions are even more important
* There are new realities of patient populations driving open source even faster
* How to use open source reliably and and securely in a safety-critical environment like medical devices
Driving Performance Excellence in the Regulatory Affairs Function at Medical ...Best Practices
Optimizing the resource and staffing levels at medical device companies enables Regulatory Affairs leaders to prioritize roles and responsibilities, thereby driving organizational growth.
Research & Consulting leader, Best Practices, LLC engaged Regulatory Affairs leaders at 32 leading medical device companies through a benchmarking survey to capture insights regarding current and future trends shaping the Regulatory Affairs function. This study delivers benchmarks around the critical drivers of regulatory performance excellence at medical device companies.
Download Full Report: http://bit.ly/2asHvQh
Globalization of Clinical Trials: Mutual acceptance of Medical Device dataAnnet Visscher
Technologies and regulatory standards facilitate clinical trial globalization and mutual acceptance of clinical trial data. Changes in trial execution, however, are not 1:1 reflected in foreign data acceptance. Factors such as ethnic and local requirements seem to outweigh the benefits.
Update on software as a medical device (SaMD)TGA Australia
This presentation will explore the definition of a medical device and how this applies to software. In addition, the nuances of the kinds of software will be discussed in relation to their likely classification as a medical device.
The Breast International Group (BIG) is the largest international network of academic breast cancer research groups. Facilitating international clinical trials is BIG's core expertise and for that reason, we have developed a slideshare presentation to explain the basics of clinical trials.
Creating Interoperable Medical Devices that fit into Hospital Enterprise IT E...Shahid Shah
Creating connected medical devices is challenging but doing so in an interoperable manner that can easily and flexibly fit into modern hospital IT environments is even more difficult. This presentation provides sage advice on how to design connected life-critical medical devices so that they work well within modern hospital environments.
A Modern Data Strategy for Precision MedicineCloudera, Inc.
Genomics is upon us, made possible by big data and the technologies designed to support it. Doctors, who historically used clinical data, and researchers, who historically used genomic data, are now increasingly focused on analyzing the same single data set: introducing the opportunity to share bodies of knowledge, fostering collaborative innovation, and driving toward higher standards of care.
However, this data is enormous – volumes of genomic data are expected to reach two to four exabytes per year by 2025, yet the cost of genetic sequencing has decreased 100-fold over the past 10 years.
Cloudera is helping solve the big data problem with its Apache Hadoop-based platform for large-scale data processing, discovery, and analytics; putting precision medicine within reach.
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
Fraser Lewis talks at Digital Henley #4 on Wednesday 4th May regarding how RB as a FMCG business utilises (or doesn't) utilise digital data to help guide their commercial decision making.
En utilisant l’apprentissage de models sur des données collectées dans les dossiers patients d’un réseau d’hôpitaux et du machine learning, il est possible de prédire le risque de ré-hospitalisation dans 30 ou 90 jours pour des insuffisants cardiaque. Valère présente la création d’un Cloud Collaboratif sur le Cancer qui offre la possibilité aux Hôpitaux des Etats Unis de donner accès à un très grand nombre de dossiers patients atteint du Cancer.
Denver, CO – June 23, 2014 - The Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA. The announcement is made by CBSA President & CEO April Giles, who says, “In this issue we are looking at the intersection of people and data, and how it benefits human health. Big Data is now playing a critical role within the bioscience industry—from the personal devices on our wrists monitoring our bodies, to electronic medical records housing our health histories—data is valuable.”
Drawing upon our extensive healthcare knowledge and dedicated technology and data protection teams, we will consider how to navigate the potential pitfalls of using technology to provide remote consultations, both within the UK and further afield.
Through the consideration of a case study, our speakers will analyse:
• the regulatory regime - CQC registration, indemnity chains, insurance
• protecting IP - cloud based computing and contractual protections
• E-commerce - on-line payments and cooling off periods
• DPA and IG - risk when providing services overseas and what happens if IG is breached.
Can AI do good? at 'offtheCanvas' India HCI preludeAlan Dix
Invited talk at 'offtheCanvas' IndiaHCI prelude, 29th June 2024.
https://www.alandix.com/academic/talks/offtheCanvas-IndiaHCI2024/
The world is being changed fundamentally by AI and we are constantly faced with newspaper headlines about its harmful effects. However, there is also the potential to both ameliorate theses harms and use the new abilities of AI to transform society for the good. Can you make the difference?
Fonts play a crucial role in both User Interface (UI) and User Experience (UX) design. They affect readability, accessibility, aesthetics, and overall user perception.
PDF SubmissionDigital Marketing Institute in NoidaPoojaSaini954651
https://www.safalta.com/online-digital-marketing/advance-digital-marketing-training-in-noidaTop Digital Marketing Institute in Noida: Boost Your Career Fast
[3:29 am, 30/05/2024] +91 83818 43552: Safalta Digital Marketing Institute in Noida also provides advanced classes for individuals seeking to develop their expertise and skills in this field. These classes, led by industry experts with vast experience, focus on specific aspects of digital marketing such as advanced SEO strategies, sophisticated content creation techniques, and data-driven analytics.
EASY TUTORIAL OF HOW TO USE CAPCUT BY: FEBLESS HERNANEFebless Hernane
CapCut is an easy-to-use video editing app perfect for beginners. To start, download and open CapCut on your phone. Tap "New Project" and select the videos or photos you want to edit. You can trim clips by dragging the edges, add text by tapping "Text," and include music by selecting "Audio." Enhance your video with filters and effects from the "Effects" menu. When you're happy with your video, tap the export button to save and share it. CapCut makes video editing simple and fun for everyone!
Visual Style and Aesthetics: Basics of Visual Design
Visual Design for Enterprise Applications
Range of Visual Styles.
Mobile Interfaces:
Challenges and Opportunities of Mobile Design
Approach to Mobile Design
Patterns
White wonder, Work developed by Eva TschoppMansi Shah
White Wonder by Eva Tschopp
A tale about our culture around the use of fertilizers and pesticides visiting small farms around Ahmedabad in Matar and Shilaj.
When Digital Meets Medical: The Next Generation Clinical Trial
1. WHEN DIGITAL MEETS MEDICAL:
THE NEXT GENERATION CLINICAL TRIAL
Celine Pering
NOVEMBER 07, 2014
MEDICAL DEVICE DESIGN CONFERENCE, IDSA
2. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 2
Small ingestible sensor
Sensor is embedded
within your medication
3. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 3
Part of a multi touch-point system
Patient
Patch
Your Medication
See Daily Patterns
Via a Mobile Device
Patient
Doctor
4. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 4
A complex ecosystem of stakeholders
5. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 5
Cross-pollinating clinical research with
consumer research can open up a whole
new discipline ripe for exploration
11. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 11
These are two very different industries
Consumer Products Medical Devices
12. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 12
Self-directed purchase
These are two very different industries
Consumer Products
Prescribed
Medical Devices
13. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 13
Self-directed purchase
Payor is the end user
These are two very different industries
Consumer Products
Prescribed
Payor is a separate stakeholder
Medical Devices
14. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 14
Self-directed purchase
Payor is the end user
Straightforward path
These are two very different industries
Consumer Products
Prescribed
Payor is a separate stakeholder
Interdependent ecosystem
Medical Devices
15. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 15
Self-directed purchase
Payor is the end user
Straightforward path
Lightning fast
These are two very different industries
Consumer Products
Prescribed
Payor is a separate stakeholder
Interdependent ecosystem
Slow moving
Medical Devices
16. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 16
Self-directed purchase
Payor is the end user
Straightforward path
Lightning fast
Partially regulated
These are two very different industries
Consumer Products
Prescribed
Payor is a separate stakeholder
Interdependent ecosystem
Slow moving
Heavily regulated
Medical Devices
17. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 17
Self-directed purchase
Payor is the end user
Straightforward path
Lightning fast
Partially regulated
Status symbol
These are two very different industries
Consumer Products
Prescribed
Payor is a separate stakeholder
Interdependent ecosystem
Slow moving
Heavily regulated
Stigmatizing symbol
Medical Devices
18. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 18
Self-directed purchase
Payor is the end user
Straightforward path
Lightning fast
Partially regulated
Status symbol
These are two very different industries
Consumer Products
Prescribed
Payor is a separate stakeholder
Interdependent ecosystem
Slow moving
Heavily regulated
Stigmatizing symbol
Medical Devices
20. A mature field based on a long history of drug development
Clinical research
Saving Lives
Safety
Checks and Balances
Regulation
Targeted Medicine
1740
1930
1940
1970
1990
2000
Future
Sailor Scurvy
James Lind
FDA Formed
Elixir Sulfanilamide
War Crimes
Nuremberg Trial
Pharma Growth
Stronger Patents
Personalization
Technology Advancement
21. Design problems are quickly becoming more complex
Product design
Saving Lives Safety Checks and Balances Regulation Targeted Medicine
1740 1930
Physical, Singular Products Social Systems
1940 1970 1990 2000 Future
Genius Design
Philip Stark
Sailor Scurvy
James Lind
FDA Formed
Elixir Sulfanilamide
War Crimes
Nuremberg Trial
Pharma Growth
Stronger Patents
Personalization
Technology Advancement
Industrial Design
Henry Dreyfuss
Design Thinking
d.school
Product Design
Smart Design
Social Innovation
Social Problems
22. Evolving at a fast pace while regulation is still being defined
Medical device regulation
Saving Lives Safety Checks and Balances Regulation Targeted Medicine
1740 1930
Physical, Singular Products Social Systems
1940 1970 1990 2000 Future
Genius Design
Philip Stark
Sailor Scurvy
James Lind
FDA Formed
Elixir Sulfanilamide
War Crimes
Nuremberg Trial
Pharma Growth
Stronger Patents
Personalization
Technology Advancement
Industrial Design
Henry Dreyfuss
Design Thinking
d.school
Product Design
Smart Design
Social Innovation
Social Problems
Medical Device Act
Dalkon Shield IUD
HF Requirements
FDA Regulations
Regulatory Gray Area
mHealth, today
23. Working at the cutting edge presents new opportunities
Today
Saving Lives Safety Checks and Balances Regulation Targeted Medicine
1740 1930
Physical, Singular Products Social Systems
1940 1970 1990 2000 Future
Genius Design
Philip Stark
Sailor Scurvy
James Lind
FDA Formed
Elixir Sulfanilamide
War Crimes
Nuremberg Trial
Pharma Growth
Stronger Patents
Personalization
Technology Advancement
Industrial Design
Henry Dreyfuss
Design Thinking
d.school
Product Design
Smart Design
Social Innovation
Social Problems
Medical Device Act
Dalkon Shield IUD
HF Requirements
FDA Regulations
Regulatory Gray Area
mHealth, today
24. 1 CALL TO ACTION
2 OPPOSITE ENDS OF THE SPECTRUM
25. Exploring the world,
discovering nuanced
differences and subtle
similarities Photo Credit: Jan Chipchase
26. Design research is
experiencing its
Wild West
Photo Credit: Jan Chipchase
27. In contrast, ethics
committees assess
compliance in clinical
research Photo Credit: Credit Willis Ryder Arnold
31. Generative
Empathetic
Adaptive
Opposite ends of the spectrum
Design Research
Evaluative
Prescriptive
Systematic
Clinical Research
32. Generative
Empathetic
Adaptive
Personal
Opposite ends of the spectrum
Design Research
Evaluative
Prescriptive
Systematic
Double-blind
Clinical Research
33. Generative
Empathetic
Adaptive
Personal
Opposite ends of the spectrum
Design Research
Evaluative
Prescriptive
Systematic
Double-blind
Clinical Research
35. 1 CALL TO ACTION
EXPLORATION AS A METAPHOR 3 2
OPPOSITE ENDS OF THE SPECTRUM
36. We are charting new territory using skills
from existing practices
Photo Credit: National Geographic
37. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 37
Boundaries 12345
Principles
These 5 major principles enabled us to cross-pollinate
best practices
Stretching
Collaboration
Umbrellas
Constraints
38. 1
Where do the boundaries exist when disciplines are mixed?
Can you take photos?
Can you know people’s names?
PRINCIPLES
Boundaries
Photo Credit: Christine Genius
39. 2
This work is not business as usual. This requires stretching past comfort zones all around and getting your extended team onboard.
PRINCIPLES
Stretching
40. 3
Sharing the study design across departments helps cross-pollinate ideas.
PRINCIPLES
Collaboration
41. 4
Strategic protocol umbrellas help provide wiggle room. By setting these up in advance, sub-studies are quicker to conduct and get faster IRB approval.
PRINCIPLES
Umbrellas
42. 5
Work within the constraints. There are ways to be creative even within restrictive bounds.
PRINCIPLES
Constraints
43. 1 CALL TO ACTION
3 EXPLORATION AS A METAPHOR
4A NEW DISCIPLINE
2 OPPOSITE ENDS OF THE SPECTRUM
44. A simplified design process
Design
Freeze
510K
Commercial
Launch
Research
Development
Evidence
Development
45. There is an opportunity to commingle methods before products are put into the formal clinical process
Design Research
Clinical Research
46. We have developed two new methods that enable the convergence of design and clinical research
Design Research
Clinical Research
Methodology #2 “CLUE”
Methodology #1 “RCS”
47. “RCS” studies (Research for Component Selection)
An umbrella clinical protocol used for usability testing or
engineering experimentation
48. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 48
QUESTIONS:
“RCS” Methodology:
Research for Component Selection 1
What form factor stays on the body longest?
What feels the most comfortable?
How does the wear experience change over time?
CHALLENGE:
Anything that is stuck on the body needs IRB approval.
There is no replacement for living human skin.
49. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 49
SAMPLE FINDINGS:
“RCS” Methodology:
Exploring the effectiveness of different prototypes 1
Wear time of prototype
is 4 days compared to 7
days with the control.
The “banana slug” was the
least favorite. Too rigid.
The more flexible form
factor was preferred.
50. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 50
CONTEXTUALIZED:
“RCS” Methodology:
Working with prototypes, quickly and cheaply 1
User Preference Testing
RCS
Clinical Research
ON THE BODY REAL USE R&D
51. “CLUE” studies (Clinical User Experience)
Allow design researchers to work directly with clinical trial
participants, allowing us to quickly try out the market
52. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 52
QUESTIONS:
“CLUE” Methodology:
Clinical User Experience 2
How does this “beta” product work in real, live use?
Do people understand it “in the wild?”
What is the vulnerable population’s experience using the product?
CHALLENGE:
This is very expensive research.
53. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 53
SAMPLE FINDINGS:
“CLUE” Methodology:
Understanding emotions, attitudes and behaviors 2
Frustration with the on-boarding
experience
“Green light” provides re-assurance
Concern about discretion
with a slinky black dress
54. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 54
SAMPLE FINDINGS:
“CLUE” Methodology:
Mapping the emotional experience 2
Emotional
highs and
lows
55. When Digital Meets Medical, IDSA Medical Device Design Conference November 07, 2014 Twitter @ProteusDH 55
CONTEXTUALIZED:
“CLUE” Methodology:
Gaining insight into real use while still in a clinical context 2
Ethnography
CLUE
Clinical Research
ON THE BODY REAL USE ATTITUDES &
BEHAVIOR
R&D
56. 1 CALL TO ACTION
3 EXPLORATION AS A METAPHOR
4A NEW DISCIPLINE
5 TAKEAWAYS
2 OPPOSITE ENDS OF THE SPECTRUM
57. This is a form of integrating
insight and evidence-building
methods
61. Contact me:
Interested in forming a workgroup to compare best practices?
Celine Pering
Director, Human Factors and User Research
cpering@proteusdh.com
Proteus Digital Health
2600 Bridge Parkway, Suite 101
Redwood City, CA 94065
62. Thank You!
Celine Pering
Director, Human Factors and User Research
cpering@proteusdh.com
Proteus Digital Health
2600 Bridge Parkway, Suite 101
Redwood City, CA 94065